Possible Protective Effect of Celecoxib Against Capecitabine Induced Hand and Foot Syndrome in Patients With Colorectal Cancer

Clinical trial NCT05327751 · UNKNOWN

Trial details

NCT number: NCT05327751
Sponsor: Tanta University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Hand and Foot Syndrome Erythrodysesthesia Syndrome HFS Colorectal Cancer

Start date: 2022-04-01
Primary completion: 2024-04-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.